Releases
Found 39021 articles
Peabody Energy Faces Class Action Over Centurion Mine Disclosures
Investors who held Peabody Energy stock between October 2024 and May 2026 are facing a potential financial reckoning after a class action lawsuit alleged the company misled the market regarding the production trajectory of its Centurion mine. The legal action centers on claims of material misstatements regarding operational progress.
Photronics Faces Class Action Lawsuit Over Alleged Misleading Statements
Investors who purchased Photronics, Inc. shares between December 10, 2025, and May 27, 2026, are being urged to join a class action lawsuit. The DJS Law Group filed the action, alleging that the company misled the market regarding the strength of its high-end product pipeline and business momentum.
AeroVironment Faces Class Action Lawsuit Over Alleged Market Misleading
Investors who purchased AeroVironment, Inc. stock between June 25, 2025, and March 10, 2026, are being urged to contact DJS Law Group regarding a securities class action. The lawsuit alleges that the company misled shareholders concerning its competitive standing for U.S. Space Force contracts.
Laura Chaubard to Lead Sopra Steria’s Defence and Space Division
Laura Chaubard, the former Director General of École Polytechnique and a General Engineer of Armament, will assume leadership of Sopra Steria’s Defence, Security and Space vertical on September 1, 2026. Her appointment signals a shift toward bolstering European technological sovereignty amid surging regional military spending.
Investors Launch Securities Class Action Against Badger Meter
Shareholders of Badger Meter, Inc. have initiated a class action lawsuit alleging the company misled the market regarding its financial health. The complaint claims the firm artificially bolstered its performance by pulling forward customer orders while publicly attributing success to sustainable growth drivers during the period from April 2024 to April 2026.
ADMA Biologics Faces Class Action Over Alleged Securities Violations
Investors who purchased ADMA Biologics stock between August 9, 2024, and March 25, 2026, are being urged to join a class action lawsuit. The DJS Law Group is spearheading the litigation, alleging that the company misled the market regarding its financial health and internal sales practices.
BitGo Holdings Faces Class Action Over IPO Disclosures
Investors who purchased BitGo Holdings stock following the company’s January 22, 2026, initial public offering are now part of a federal securities class action. The lawsuit alleges that BitGo misled the market by inflating its financial outlook while obscuring the impact of declining digital asset prices on its operations.
.jpg)
Black Rock Coffee Faces Securities Lawsuit Over Growth Claims
Investors who purchased Black Rock Coffee Bar shares between September 12, 2025, and May 12, 2026, are being urged to join a class action lawsuit. The litigation targets the company for allegedly issuing misleading statements regarding its store expansion strategy and the impact of new locations on existing performance.
Investors Initiate Class Action Against Calix Over Margin Misstatements
Investors who purchased Calix, Inc. shares between January 28 and April 21, 2026, face a July 27 deadline to join a class action lawsuit. The litigation alleges the company issued misleading public statements regarding its quarterly performance and the impact of memory module procurement on its bottom line.
Investors Urged to Join GeneDx Securities Fraud Class Action
The Schall Law Firm is rallying investors to participate in a class action lawsuit against GeneDx Holdings Corp. following allegations of misleading financial disclosures. Shareholders who acquired securities between April 16, 2025, and May 4, 2026, have until August 3, 2026, to join the litigation regarding potential violations of federal securities laws.
Laura Chaubard to lead Sopra Steria’s Defence, Security and Space unit
Laura Chaubard, the former Director General of École Polytechnique, will oversee Sopra Steria’s Defence, Security and Space vertical starting September 1, 2026. Her transition to the Group Executive Committee signals a strategic push to deepen the firm’s influence in European sovereign technology and critical infrastructure.
Erasca Faces Class Action Lawsuit Over Misleading Drug Development Claims
Investors who purchased Erasca, Inc. shares between January 14, 2025, and April 26, 2026, are being urged to join a class action lawsuit. The litigation, filed by the DJS Law Group, alleges that the company violated federal securities laws by misrepresenting the patent status and viability of its ERAS-0015 drug candidate.
Embecta Faces Class Action Lawsuit Over Alleged Securities Violations
Investors who purchased Embecta Corp. stock between November 25, 2025, and May 4, 2026, are being urged to join a class action lawsuit. The DJS Law Group filed the action alleging that the company misled shareholders regarding the stability of its fiscal guidance and market challenges.
Investors Target First Solar in Securities Fraud Class Action
The DJS Law Group has opened a class action lawsuit against First Solar, Inc., alleging the company misled shareholders regarding its manufacturing shift from Asia to the United States. The complaint centers on claims that the solar manufacturer misrepresented its ability to navigate international trade tariffs throughout 2025.
L'Oréal and Louis Theroux Headline UNLEASH Paris HR Summit
Eight thousand five hundred senior leaders from 140 countries will converge at the Paris Convention Centre this October to address a singular challenge: how to fundamentally reinvent the nature of work in the age of artificial intelligence for a collective workforce exceeding 100 million employees.
Gerald Group Secures US$50 Million ECI-Backed Financing Facility
Geneva-based commodity trader Gerald Group has closed a US$50 million, three-year finance facility backed by Etihad Credit Insurance, marking its first export credit agency-supported financing in the region. The deal, arranged through Abu Dhabi Commercial Bank, aims to bolster non-oil metals trade flows originating from the United Arab Emirates.
L'Oréal and Louis Theroux Headline UNLEASH Paris HR Summit
With 8,500 senior leaders representing 100 million global employees converging on the Paris Convention Centre from October 20–22, 2026, the UNLEASH conference marks a definitive shift toward AI-driven organizational design, moving beyond automation to embrace a new category of enterprise-wide work technology.
Shareholders Urged to Join Securities Fraud Suit Against Phreesia
Investors who purchased Phreesia, Inc. stock between May 8, 2025, and March 30, 2026, face a critical deadline to join a class action lawsuit. The Schall Law Firm is spearheading the litigation, alleging the company misled the market regarding its long-term growth projections and revenue reliability for fiscal year 2027.
Investors Launch Class Action Against Zoetis Over Misleading Claims
A federal class action lawsuit has been filed against animal health giant Zoetis Inc., alleging that the company misled shareholders regarding the performance and market challenges of key product lines. The litigation centers on potential violations of the Securities Exchange Act during an sixteen-month period ending in May 2026.
Verra Mobility Faces Class Action Over Misleading Market Statements
Investors who purchased Verra Mobility Corporation stock between February 24 and May 26, 2026, are being urged to join a class action lawsuit. The litigation alleges the company misled shareholders regarding the stability of its rental car industry partnerships, specifically concerning the loss of a major client.
Roblox Faces Securities Lawsuit Over Misleading Growth Claims
Investors who purchased Roblox Corporation stock between October 30, 2025, and April 30, 2026, are now the target of a class action lawsuit alleging violations of the Securities Exchange Act. The complaint centers on claims that the gaming company obscured the negative impact of new age-verification protocols on its growth.
Phreesia Faces Class Action Lawsuit Over Alleged Misleading Growth Claims
Investors who purchased Phreesia, Inc. stock between May 8, 2025, and March 30, 2026, face a July 13 deadline to join a class action lawsuit. The litigation alleges the company misled shareholders by projecting reliable fiscal year 2027 growth despite underlying industry volatility that threatened its core revenue streams.
Schall Law Firm Targets PicS N.V. Over Alleged IPO Misconduct
Investors who purchased PicS N.V. securities following the company’s January 30, 2026, initial public offering now have until August 4 to join a class action lawsuit. The Schall Law Firm alleges the company misled shareholders by overstating the quality of its underwriting practices and concealing significant financial risks.
ALZpath Antibody Anchors Alzheimer’s Research at AAIC 2026
Eighty-six scientific presentations at this year's Alzheimer's Association International Conference in London highlight the role of ALZpath’s proprietary pTau217 antibody. As blood-based testing gains momentum, the company’s diagnostic tool has become a critical standard for academic and clinical research programs aiming to detect amyloid pathology earlier.
AutoShop Answers Taps Industry Veteran George Zeeks for Growth Role
George Zeeks, a veteran with two decades of experience in the automotive aftermarket, has been appointed Vice President of Growth & Development at AutoShop Answers. The Houston-based company, a division of the Houston Boston Partnership, is leveraging the hire to accelerate its national expansion and leadership development services.
Lighthouse Pharmaceuticals Links Gingipain Inhibition to Behavioral Gains
Forty-eight weeks of treatment with the gingipain inhibitor atuzaginstat significantly curbed agitation, aggression, and caregiver distress in patients testing positive for Porphyromonas gingivalis. These findings, presented at the Alzheimer’s Association International Conference 2026, suggest a potential path to managing the most taxing behavioral symptoms of the disease.
Eisai’s Etalanetug Shows Promise in Targeting Alzheimer’s Tau Pathology
Experimental anti-tau antibody etalanetug significantly reduced levels of the plasma biomarker eMTBR-tau243 in patients with dominantly inherited Alzheimer’s disease, according to new data presented at the 2026 Alzheimer’s Association International Conference in London. The findings suggest a potential shift toward less invasive diagnostic and monitoring tools for the neurodegenerative condition.
Zoetis Investors Face Class Action Lawsuit Over Alleged Market Misleading
Investors who held shares in Zoetis Inc. between January 14, 2025, and May 6, 2026, are being urged to join a class action lawsuit filed by The Schall Law Firm. The litigation centers on claims that the pharmaceutical company issued false statements regarding its core veterinary product performance.
The Leela Named World's Second-Best Hotel Brand in 2026 T+L Rankings
Voters in the 2026 Travel + Leisure World's Best Awards have propelled The Leela Palaces, Hotels and Resorts to the second spot globally, cementing the Indian chain's standing among the elite of international luxury hospitality as it marks four decades of operation.
Schall Law Firm Targets Genius Group Over Alleged Spoofing Scheme
Investors who held Genius Group Limited stock between April 2022 and May 2025 face a critical window to join a pending class action lawsuit. The Schall Law Firm alleges the company misled shareholders through a market manipulation scheme, artificially inflating trading activity to mask the firm's true financial standing.